Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Payables (2017 - 2025)

Q32 Bio (QTTB) has 9 years of Payables data on record, last reported at $879000.0 in Q4 2025.

  • For Q4 2025, Payables fell 70.59% year-over-year to $879000.0; the TTM value through Dec 2025 reached $879000.0, down 70.59%, while the annual FY2025 figure was $879000.0, 70.59% down from the prior year.
  • Payables reached $879000.0 in Q4 2025 per QTTB's latest filing, down from $973000.0 in the prior quarter.
  • Across five years, Payables topped out at $9.9 million in Q1 2022 and bottomed at $879000.0 in Q4 2025.
  • Average Payables over 5 years is $3.6 million, with a median of $3.4 million recorded in 2023.
  • Peak YoY movement for Payables: surged 203.15% in 2023, then tumbled 83.88% in 2024.
  • A 5-year view of Payables shows it stood at $2.4 million in 2021, then crashed by 51.65% to $1.1 million in 2022, then soared by 203.15% to $3.5 million in 2023, then fell by 13.81% to $3.0 million in 2024, then plummeted by 70.59% to $879000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Payables were $879000.0 in Q4 2025, $973000.0 in Q3 2025, and $910000.0 in Q2 2025.